Stewie
Featured Member / Verified Customer
Featured Member
Kilo Klub Member
Registered
Verified Customer
- Joined
- Feb 3, 2011
- Messages
- 5,178
Also
**broken link removed**
exemestane /exe·mes·tane/ (ek″sĕ-mes´tān) an aromatase inactivator related to androstenedione; used as an antineoplastic.
Dorland's Medical Dictionary for Health Consumers. © 2007 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
exemestane,
an antineoplastic.
indication It is used to treat advanced breast cancer in postmenopausal patients whose cancer is unresponsive to other therapies.
contraindications The use is prohibited in pre-menopausal women, pregnant women, and clients with known hypersensitivity to this drug.
adverse effects Adverse effects include fatigue, diarrhea, constipation, abdominal pain, increased appetite, hypertension, depression, insomnia, anxiety, cough, and dyspnea. Common side effects include nausea, vomiting, hot flashes, and headache.
Mosby's Medical Dictionary, 8th edition. © 2009, Elsevier.
exemestane [ek″sĕ-mes´tān]
an aromatase inactivator structurally related to androstenedione; used as an antineoplastic in the treatment of advanced breast carcinoma in postmenpausal women, administered orally.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
exemestane Warning - High-alert drug!
Aromasin
Pharmacologic class: Aromatase inhibitor
Therapeutic class: Hormonal antineoplastic
Pregnancy risk category D
Action
Inhibits conversion of androgens to estrogen, which reduces estrogen concentrations and limits cancer cell growth in estrogen-dependent breast tumors
Availability
Tablets: 25 mg
⊘Indications and dosages
➣ Advanced breast cancer
Adults: 25 mg P.O. once daily after a meal
Contraindications
• Hypersensitivity to drug or its components
Precautions
Use cautiously in:
• moderate to severe hepatic insufficiency or renal impairment
• concurrent use of estrogen-containing drugs
• premenopausal women
• pregnant or breastfeeding patients
• children (safety and efficacy not established).
Administration
• Administer after meals with a full glass of water.
• Know that drug shouldn't be taken by premenopausal women or by patients receiving drugs that contain estrogen.
Route Onset Peak Duration
P.O. Unknown 1-2 hr 24 hr
Adverse reactions
CNS: headache, dizziness, confusion, asthenia, fatigue, weakness, hypoesthesia, paresthesia, pain, anxiety, insomnia, depression
CV: hypertension, chest pain
EENT: sinusitis
GI: nausea, vomiting, diarrhea, constipation, abdominal pain, dyspepsia, anorexia
GU: urinary tract infection
Musculoskeletal: pathologic fractures, arthritis, back pain, skeletal pain
Respiratory: dyspnea, cough, bronchitis, upper respiratory tract infection
Skin: rash, itching, alopecia, diaphoresis
Other: increased appetite, fever, hot flashes, infection, flulike symptoms, edema, lymphedema
Interactions
Drug-drug. CYP3A4 inducers: decreased exemestane blood level
Patient monitoring
• Monitor vital signs, especially blood pressure.
• Check for adverse GI reactions. Give antiemetics, as prescribed, for nausea and vomiting.
• Assess bowel elimination pattern. Increase fluids and administer stool softeners, as needed, to ease constipation.
• Monitor pain level. Administer analgesics, as prescribed, to relieve pain.
• Monitor liver function tests, CBC, and blood urea nitrogen, creatinine, and electrolyte levels.
Patient teaching
• Advise patient to take with full glass of water after a meal.
• Tell patient to report depression, insomnia, or excessive anxiety.
• Instruct patient to wear cotton clothing to let skin breathe if drug causes increased sweating or hot flashes.
• As appropriate, review all other significant adverse reactions and interactions, especially those related to the drugs mentioned above.
**broken link removed**
exemestane /exe·mes·tane/ (ek″sĕ-mes´tān) an aromatase inactivator related to androstenedione; used as an antineoplastic.
Dorland's Medical Dictionary for Health Consumers. © 2007 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
exemestane,
an antineoplastic.
indication It is used to treat advanced breast cancer in postmenopausal patients whose cancer is unresponsive to other therapies.
contraindications The use is prohibited in pre-menopausal women, pregnant women, and clients with known hypersensitivity to this drug.
adverse effects Adverse effects include fatigue, diarrhea, constipation, abdominal pain, increased appetite, hypertension, depression, insomnia, anxiety, cough, and dyspnea. Common side effects include nausea, vomiting, hot flashes, and headache.
Mosby's Medical Dictionary, 8th edition. © 2009, Elsevier.
exemestane [ek″sĕ-mes´tān]
an aromatase inactivator structurally related to androstenedione; used as an antineoplastic in the treatment of advanced breast carcinoma in postmenpausal women, administered orally.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
exemestane Warning - High-alert drug!
Aromasin
Pharmacologic class: Aromatase inhibitor
Therapeutic class: Hormonal antineoplastic
Pregnancy risk category D
Action
Inhibits conversion of androgens to estrogen, which reduces estrogen concentrations and limits cancer cell growth in estrogen-dependent breast tumors
Availability
Tablets: 25 mg
⊘Indications and dosages
➣ Advanced breast cancer
Adults: 25 mg P.O. once daily after a meal
Contraindications
• Hypersensitivity to drug or its components
Precautions
Use cautiously in:
• moderate to severe hepatic insufficiency or renal impairment
• concurrent use of estrogen-containing drugs
• premenopausal women
• pregnant or breastfeeding patients
• children (safety and efficacy not established).
Administration
• Administer after meals with a full glass of water.
• Know that drug shouldn't be taken by premenopausal women or by patients receiving drugs that contain estrogen.
Route Onset Peak Duration
P.O. Unknown 1-2 hr 24 hr
Adverse reactions
CNS: headache, dizziness, confusion, asthenia, fatigue, weakness, hypoesthesia, paresthesia, pain, anxiety, insomnia, depression
CV: hypertension, chest pain
EENT: sinusitis
GI: nausea, vomiting, diarrhea, constipation, abdominal pain, dyspepsia, anorexia
GU: urinary tract infection
Musculoskeletal: pathologic fractures, arthritis, back pain, skeletal pain
Respiratory: dyspnea, cough, bronchitis, upper respiratory tract infection
Skin: rash, itching, alopecia, diaphoresis
Other: increased appetite, fever, hot flashes, infection, flulike symptoms, edema, lymphedema
Interactions
Drug-drug. CYP3A4 inducers: decreased exemestane blood level
Patient monitoring
• Monitor vital signs, especially blood pressure.
• Check for adverse GI reactions. Give antiemetics, as prescribed, for nausea and vomiting.
• Assess bowel elimination pattern. Increase fluids and administer stool softeners, as needed, to ease constipation.
• Monitor pain level. Administer analgesics, as prescribed, to relieve pain.
• Monitor liver function tests, CBC, and blood urea nitrogen, creatinine, and electrolyte levels.
Patient teaching
• Advise patient to take with full glass of water after a meal.
• Tell patient to report depression, insomnia, or excessive anxiety.
• Instruct patient to wear cotton clothing to let skin breathe if drug causes increased sweating or hot flashes.
• As appropriate, review all other significant adverse reactions and interactions, especially those related to the drugs mentioned above.